HERITAGE PHARMA AVET
GenericsHERITAGE PHARMA AVET is a generic drug manufacturer focused on Gastroenterology, Infectious Disease.
HERITAGE PHARMA AVET's Key Drugs
HERITAGE PHARMA AVET's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
HERITAGE PHARMA AVET's Recent FDA Approvals
New NDA/BLA approvals for HERITAGE PHARMA AVET over the last two years — novel drugs only, excluding generics and label supplements.
HERITAGE PHARMA AVET's Therapeutic Areas
HERITAGE PHARMA AVET's approved drugs and pipeline span 2 therapeutic areas, led by Gastroenterology and Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
HERITAGE PHARMA AVET's Top Competitors
HERITAGE PHARMA AVET's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
HERITAGE PHARMA AVET Pipeline Snapshot
Active clinical trials for HERITAGE PHARMA AVET across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Gastroenterology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1983-11-08
- Latest
- 2026-06-03
- Applications
- 26